Implementing health technology assessment in Ghana to support universal health coverage: building relationships that focus on people, policy, and process.


Journal

International journal of technology assessment in health care
ISSN: 1471-6348
Titre abrégé: Int J Technol Assess Health Care
Pays: England
ID NLM: 8508113

Informations de publication

Date de publication:
2020
Historique:
pubmed: 30 11 2019
medline: 15 12 2020
entrez: 29 11 2019
Statut: ppublish

Résumé

Ghana is one of the few African countries to enact legislation and earmark significant funding to establish universal health coverage (UHC) through the National Health Insurance Scheme, although donor funds have declined recently. Given a disproportionate level of spending on medicines, health technology assessment (HTA) can support resource allocation decisions in the face of highly constrained budgets, as commonly found in low-resource settings. The Ghanaian Ministry of Health, supported by the International Decision Support Initiative (iDSI), initiated a HTA study in 2016 to examine the cost-effectiveness of antihypertensive medicines. We aimed to summarize key insights from this work that highlights success factors beyond producing purely technical outputs. These include the need for capacity building, academic collaboration, and ongoing partnerships with a broad range of experts and stakeholders. By building on this HTA study, and with ongoing interactions with iDSI, HTAi, WHO, and others, Ghana will be well positioned to institutionalize HTA in resource allocation decisions and support progress toward UHC.

Identifiants

pubmed: 31775950
doi: 10.1017/S0266462319000795
pii: S0266462319000795
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

8-11

Auteurs

Samantha Hollingworth (S)

School of Pharmacy, University of Queensland, 20 Cornwall St, Woolloongabba, QLD 4102, Australia.

Martha Gyansa-Lutterodt (M)

Director of Pharmaceutical Services, Ministry of Health, P.O. Box M 44 Ministries, Accra, Ghana.

Lydia Dsane-Selby (L)

National Health Insurance Authority, No. 36, 6th Avenue, Ridge Residential Area, Accra, Ghana.

Justice Nonvignon (J)

School of Public Health, University of Ghana, P.O. Box LG 25, Legon, Accra, Ghana.

Ruth Lopert (R)

Université de Strasbourg, 4 rue Blaise Pascal - CS 90032 - F-67081, Strasbourg, France.
Department of Health Policy & Management, George Washington University, Washington, DC, USA.

Mohamed Gad (M)

Health Economics, School of Public Health, Imperial College London, LondonW2 1PG, UK.

Francis Ruiz (F)

School of Public Health, Imperial College London, LondonW2 1PG, UK.

Sean Tunis (S)

Centre for Medical Technology Policy, 401 E Pratt St # 631, Baltimore, MD21202, USA.

Kalipso Chalkidou (K)

iDSI, School of Public Health, Imperial College London, LondonW2 1PG, UK.
Center for Global Development, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH